Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on October 31st, 2016% Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials. . . . → Read More: Institutes, Companies Form Business to Bridge Discovery Gap
By Alan, on October 31st, 2016% Foundation Medicine, a cancer diagnostics company, and Sarah Cannon Research Institute plan to apply genomic testing of patients’ tumors in clinical trials of personalized treatments. . . . → Read More: Foundation Medicine, Sarah Cannon Partner on Cancer Trials
By Alan, on October 28th, 2016% Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary. . . . → Read More: Biotech, Univ of Miami Spin-Off Vaccine Company
By Alan, on October 28th, 2016% A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children. . . . → Read More: Preventive Drugs Offer No Benefit for Children’s Migraine
By Alan, on October 27th, 2016% A system that combines human airway tissue on a chip with components that simulate cigarette smoking is being developed to test treatments for lung disorders. . . . → Read More: Organ Chip System Designed to Simulate Smoking Effects
By Alan, on October 27th, 2016% A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year. . . . → Read More: Skin Patch Shown to Increase Peanut Tolerance in Children
By Alan, on October 26th, 2016% A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil. . . . → Read More: Engineered Mosquito Production Facility Opens
By Alan, on October 26th, 2016% A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities. . . . → Read More: Trial to Test Drug Combination for Hospital Infections
By Alan, on October 25th, 2016% A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants. . . . → Read More: ALS Soy Peptide Trial Completes Enrollment
By Alan, on October 25th, 2016% Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes. . . . → Read More: Google Acquires Visual Interaction Tech Company
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|